A year after adults in the U.S. began getting vaccinated against COVID-19, children ages 5 and up are now eligible for the shot. So far, uptake has been slow – in part because of parents’ concerns over vaccine safety.

On the latest episode of The Dose, pediatrician and American Academy of Pediatrics board member Michelle Fiscus, M.D., and the Commonwealth Fund’s Rachel Nuzum shed light on challenges and opportunities in raising child vaccination rates.

One downstream concern is a growing trend of resistance to other childhood vaccines. As Dr. Fiscus says, if “vaccine hesitancy continues to build with the routine childhood vaccines, I am very concerned about the types of outbreaks that we're going to be fighting over the next years.”